Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial 99mTc-macroaggregated albumin administration in patients with bone and soft-tissue tumors

Journal of Nuclear Medicine

Volumn 43, Issue 11, 2002, Pages 1452-1456

  Taki, Junichi ^a   Sumiya, Hisashi ^a   Higuchi, Takahiro ^a   Tsuchiya, Hiroyuki ^a   Takazawa, Koutaro ^a   Tomita, Katsuro ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

99mTc macroaggregated albumin; Drug distribution; Intra arterial chemotherapy; Myocutaneous inflammatory change

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN; MACROSALB TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; IMAGING; MALE; MUSCLE NECROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CISPLATIN; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLAMMATION; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NECROSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SKIN; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0036840171     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP) - Angiographic, pathologic, and pharmacologic studies. Cancer. 1983;51:402-407.
2. Eilber FR, Eckhardt J, Morton DL. Advances in the treatment of sarcomas of the extremity: Current status of limb salvage. Cancer. 1984;54:2695-2701.
3. Kempf RA, Irwin LE, Menendez L, et al. Limb salvage surgery for bone and soft tissue sarcoma: A phase II pathologic study of preoperative intraarterial cisplatin. Cancer. 1991;68:738-743.
4. Petrilli AS, Gentil FC, Epelman S, et al. Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer. 1991;68:733-737.
5. Tsuchiya H, Tomita K, Mori Y, et al. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res. 1998;18:657-666.
6. Bacci G, Picci P, Ruggieri P, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities: The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer. 1990;65:2539-2553.
7. Kashdan BJ, Sullivan KL, Lackman RD, et al. Extremity osteosarcomas: Intraarterial chemotherapy and limb-sparing resection with 2-year follow-up. Radiology. 1990;177:95-99.
8. Shani J, Bertram J, Russell C, et al. Noninvasive monitoring of drug biodistribution and metabolism: Studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res. 1989;49:1877-1881.
9. 99mTc-MAA scintigraphy. AJR. 1984;143:827-831.
10. Ziessman HA, Thrall JH, Yang PJ, et al. Hepatic arterial perfusion scintigraphy with Tc-99m-MAA: Use of a totally implanted drug delivery system. Radiology. 1984;152:167-172.
11. 99mTc-MAA hepatic arterial perfusion scintigraphy. AJR. 1985;145:747-751.
12. Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N. Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop. 1999;358:27-35.
13. Tsuchiya H, Morinaga T, Taki J, Sumiya H, Matsui O, Tomita K. Effect of myocutaneous inflammatory changes caused by intra-arterial chemotherapy on the outcome of patients who undergo limb-saving surgery. Cancer. 2001;91:2447-2453.
14. Blacklock JB, Wright DC, Dedrick RL. et al. Drug streaming during intra-arterial chemotherapy. J Neurosurg. 1986;64:284-291.